Clinical Trial Update: Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion [NA]

View source ↗

Summary

The clinical trial comparing TACE alone to TACE with TACI in advanced hepatocellular carcinoma with portal vein invasion has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: WITHDRAWN